Clinical Trial Update: A Study to Estimate the Effect of Formulation on the Relative Absorption of SB-751689 Administered to Healthy Women [Phase 1]

View source ↗

Summary

Phase 1 study assessing the effect of formulation on the relative absorption of SB-751689 in healthy women; the trial is completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Osteoporosis

Drugs mentioned

• SB-751689 (SB-751689)

Snippet

Sponsor: GlaxoSmithKline | Conditions: Osteoporosis | Phase 1 | Status: COMPLETED